← Back to headlines
Viatris reports positive Phase 3 results for Nefecon in Japan
Viatris announced positive results from its Japanese Phase 3 clinical trial for Nefecon, a drug for IgA nephropathy (IgAN).
29 Jun, 14:57 — 29 Jun, 14:57
Sources
Showing 1 of 1 sources
